BRIEF published on 12/02/2025 at 16:05, 11 months 7 days ago The Vanguard Group Discloses Stake in JTC plc Takeover Code Stock Trading Securities Disclosure Vanguard Group JTC Plc
BRIEF published on 12/02/2025 at 16:04, 11 months 7 days ago The Vanguard Group Discloses Interests in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
BRIEF published on 12/02/2025 at 16:03, 11 months 7 days ago Vanguard Group Discloses Position in Greencore Group Form 8.3 Takeover Code Vanguard Group Shareholding Greencore Group
PRESS RELEASE published on 12/02/2025 at 16:02, 11 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.79% interest in Qualcomm Incorporated. Additional disclosures include dealings in relevant securities Securities Disclosure Vanguard Group Dealings Qualcomm
BRIEF published on 12/02/2025 at 16:02, 11 months 7 days ago The Vanguard Group Discloses Position in Spire Healthcare Investment Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
PRESS RELEASE published on 12/02/2025 at 16:01, 11 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.50% ownership stake in American Axle & Manufacturing Holdings, Inc. with 8,897,240 relevant securities held on 01 Dec 2025 The Vanguard Group, Inc. Relevant Securities Disclosure Ownership Stake American Axle & Manufacturing Holdings, Inc.
BRIEF published on 12/02/2025 at 16:00, 11 months 7 days ago The Vanguard Group Discloses Position in Alphawave IP Group Position Disclosure Takeover Code Vanguard Group Qualcomm Alphawave IP
PRESS RELEASE published on 12/02/2025 at 16:00, 11 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.06% stake in JTC plc. Form 8.3 reveals purchase and sale of 1p ordinary shares Vanguard Group Share Purchase Stake Disclosure Share Sale JTC Plc
BRIEF published on 12/02/2025 at 15:59, 11 months 7 days ago The Vanguard Group Discloses Position in Dowlais Group plc Takeover Code Securities Disclosure Vanguard Group Financial Holdings Dowlais Group
PRESS RELEASE published on 12/02/2025 at 15:59, 11 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.73% stake in Avadel Pharmaceuticals plc. Details of holdings and recent transactions are reported The Vanguard Group Ownership Disclosure Financial Holdings Stock Transactions Avadel Pharmaceuticals Plc
Published on 11/10/2026 at 02:45, 5 hours 3 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 8 hours 38 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 8 hours 48 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 9 hours 16 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 9 hours 33 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 07:38, 9 minutes ago Elmos Semiconductor SE continues profitable growth and strong cash generation in the third quarter of 2026
Published on 11/10/2026 at 07:30, 17 minutes ago Henkel posts very strong sales growth in the third quarter
Published on 11/10/2026 at 07:30, 18 minutes ago R. STAHL sales and profitability on track after nine months – Stabilization continues as planned – Forecast for 2026 confirmed
Published on 11/10/2026 at 07:30, 18 minutes ago Infineon closes FY 2026 with record quarter; expects revenue growth of more than 20 percent and a 5-percentage-point increase in profitability for FY 2027
Published on 11/10/2026 at 07:30, 18 minutes ago AUTO1 Group appoints Jörg Pietzner as Chief Financial Officer
Published on 11/10/2026 at 07:00, 48 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 13 hours 18 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:35, 14 hours 13 minutes ago Disclosure of transactions in own shares from November 2 to November 6, 2026
Published on 11/09/2026 at 10:32, 21 hours 16 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
